IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,899 | +6.4% | 1,274,713 | 0.0% | 0.11% | +13.0% |
| Q4 2022 | $1,785 | -99.9% | 1,274,713 | +82.1% | 0.10% | +6.4% |
| Q3 2022 | $2,212,000 | -8.9% | 700,000 | 0.0% | 0.09% | -27.7% |
| Q2 2022 | $2,429,000 | -69.3% | 700,000 | 0.0% | 0.13% | -60.7% |
| Q1 2022 | $7,910,000 | +18.1% | 700,000 | 0.0% | 0.33% | +81.9% |
| Q4 2021 | $6,699,000 | +8.1% | 700,000 | 0.0% | 0.18% | +30.9% |
| Q3 2021 | $6,195,000 | -27.8% | 700,000 | 0.0% | 0.14% | -20.1% |
| Q2 2021 | $8,582,000 | -23.1% | 700,000 | 0.0% | 0.17% | -11.7% |
| Q1 2021 | $11,158,000 | +4.3% | 700,000 | 0.0% | 0.20% | -14.3% |
| Q4 2020 | $10,703,000 | -28.0% | 700,000 | -12.5% | 0.23% | -36.3% |
| Q3 2020 | $14,856,000 | +104.3% | 800,000 | +33.3% | 0.36% | +77.8% |
| Q2 2020 | $7,272,000 | +90.8% | 600,000 | -4.8% | 0.20% | +26.1% |
| Q1 2020 | $3,812,000 | -37.6% | 630,019 | 0.0% | 0.16% | -31.8% |
| Q4 2019 | $6,111,000 | – | 630,019 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |